Diagnostic criteria for systemic lupus erythematosus: A critical review

Journal of Autoimmunity

Volumn 48-49, Issue , 2014, Pages 10-13

  Yu, Cong ^a   Gershwin, M Eric ^b   Chang, Christopher ^c  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Anti nucleosome antibodies; Anti Ro; Autoantibodies; Biomarkers; Criteria; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; SM ANTIBODY;

ALOPECIA; ANTIBODY BLOOD LEVEL; ARTHRITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC CRITERIA; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOLOGIC DISEASE; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; KIDNEY DISEASE; LUPUS ARTHRITIS; MENTAL DISEASE; NEUROLOGIC DISEASE; PHOTODERMATOSIS; PHOTOSENSITIVITY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SKIN DEFECT; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTI-NUCLEOSOME ANTIBODIES; ANTI-RO; AUTOANTIBODIES; BIOMARKERS; CRITERIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; PRACTICE GUIDELINES AS TOPIC; SEVERITY OF ILLNESS INDEX;

EID: 84895896764     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2014.01.004     Document Type: Review

References (31)

1. Fries J.F., Siegel R.C. Testing the 'preliminary criteria for classification of SLE'. Ann Rheum Dis 1973, 32:171-177.
2. Wolf L., Sheahan M., McCormick J., Michel B., Moskowitz R.W. Classification criteria for systemic lupus erythematosus. Frequency in normal patients. JAm Med Assoc 1976, 236:1497-1499.
3. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
4. Passas C.M., Wong R.L., Peterson M., Testa M.A., Rothfield N.F. Acomparison of the specificity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1985, 28:620-623.
5. Levin R.E., Weinstein A., Peterson M., Testa M.A., Rothfield N.F. Acomparison of the sensitivity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1984, 27:530-538.
6. Gilboe I.M., Husby G. Application of the 1982 revised criteria for the classification of systemic lupus erythematosus on a cohort of 346 Norwegian patients with connective tissue disease. Scand J Rheumatol 1999, 28:81-87.
7. Piette J.C., Wechsler B., Francis C., Godeau P. Systemic lupus erythematosus and the antiphospholipid syndrome: reflections about the relevance of ARA criteria. JRheumatol 1992, 19:1835-1837.
8. Petri M., Orbai A.M., Alarcon G.S., Gordon C., Merrill J.T., Fortin P.R., et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012, 64:2677-2686.
9. Petri M. Review of classification criteria for systemic lupus erythematosus. Rheum Dis Clin North Am 2005, 31:245-254. vi.
10. Eilertsen G.O., Becker-Merok A., Nossent J.C. The influence of the 1997 updated classification criteria for systemic lupus erythematosus: epidemiology, disease presentation, and patient management. JRheumatol 2009, 36:552-559.
11. Sciascia S., Bertolaccini M.L., Baldovino S., Roccatello D., Khamashta M.A., Sanna G. Central nervous system involvement in systemic lupus erythematosus: overview on classification criteria. Autoimmun Rev 2013, 12:426-429.
12. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999, 42:599-608.
13. Ainiala H., Hietaharju A., Loukkola J., Peltola J., Korpela M., Metsanoja R., et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum 2001, 45:419-423.
14. Gronhagen C.M., Gunnarsson I., Svenungsson E., Nyberg F. Cutaneous manifestations and serological findings in 260 patients with systemic lupus erythematosus. Lupus 2010, 19:1187-1194.
15. Saketkoo L.A., Quinet R. Revisiting Jaccoud arthropathy as an ultrasound diagnosed erosive arthropathy in systemic lupus erythematosus. JClin Rheumatol Pract Rep Rheum Musculoskelet Dis 2007, 13:322-327.
16. Mehrani T., Petri M. Association of IgA Anti-beta2 glycoprotein I with clinical and laboratory manifestations of systemic lupus erythematosus. JRheumatol 2011, 38:64-68.
17. Mehrani T., Petri M. IgM anti-beta2 glycoprotein I is protective against lupus nephritis and renal damage in systemic lupus erythematosus. JRheumatol 2011, 38:450-453.
18. Cucnik S., Kveder T., Artenjak A., Ulcova Gallova Z., Swadzba J., Musial J., et al. Avidity of anti-beta2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Lupus 2012, 21:764-765.
19. Ippolito A., Wallace D.J., Gladman D., Fortin P.R., Urowitz M., Werth V., et al. Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity. Lupus 2011, 20:250-255.
20. Su Y., Jia R.L., Han L., Li Z.G. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus. Clin Immunol Orl Fl 2007, 122:115-120.
21. Bizzaro N., Villalta D., Giavarina D., Tozzoli R. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis. Autoimmun Rev 2012, 12:97-106.
22. Kleinnijenhuis J., van der Molen R.G., Franssen P.M., Berden J.H., van der Meer J.W., Jacobs J.F. Anti-ribosomal P antibodies as a single serological marker in SLE: lupus in disguise. Scand J Rheumatol 2013, 42:165-166.
23. Carmona-Fernandes D., Santos M.J., Canhao H., Fonseca J.E. Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profile. BMC Med 2013, 11:98.
24. Akhter E., Burlingame R.W., Seaman A.L., Magder L., Petri M. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers. Lupus 2011, 20:1267-1274.
25. Singh R.G., Usha, Rathore S.S., Behura S.K., Singh N.K. Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare. Lupus 2012, 21:1214-1218.
26. Fragoso-Loyo H., Atisha-Fregoso Y., Nunez-Alvarez C.A., Llorente L., Sanchez-Guerrero J. Utility of interferon-alpha as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus. JRheumatol 2012, 39:504-509.
27. Thanou A., Merrill J.T. Top 10 things to know about lupus activity measures. Curr Rheumatol Rep 2013, 15:334.
28. Murphy G., Lisnevskaia L., Isenberg D. Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment. Lancet 2013, 382:809-818.
29. Luijten R.K., Fritsch-Stork R.D., Bijlsma J.W., Derksen R.H. The use of glucocorticoids in systemic lupus erythematosus. After 60 years still more an art than science. Autoimmun Rev 2013, 12:617-628.
30. Michaelson J.S., Wisniacki N., Burkly L.C., Putterman C. Role of TWEAK in lupus nephritis: a bench-to-bedside review. JAutoimmun 2012, 39:130-142.
31. Cui Y., Sheng Y., Zhang X. Genetic susceptibility to SLE: recent progress from GWAS. JAutoimmun 2013, 41:25-33.